The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional efforts in the United States and around the world in health and select place-based initiatives. We strive to make a meaningful impact in these areas, employing not only our significant financial assets, but also a rigorous, results-oriented approach and a keen understanding of relevant issues, needs, and opportunities.

The American Diabetes Association’s mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.

Abbott Diabetes Care is constantly working to deliver the highest quality products and unwavering support to their customers. Consistent and accurate glucose monitoring is the foundation of any diabetes management plan so we are committed to continuous improvement in the way patients and professionals measure, track and analyze glucose levels.

Abvance Therapeutics is developing an innovative solution to address unmet needs in diabetes care.

Admetsys has developed a first-of-its-kind artificial pancreas for hospital and surgical care, leveraging adaptive learning algorithms and counterbalancing treatment of insulin and glucose.

Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes. A new model of philanthropy, Beyond Type 1 aims to change what it means to live with chronic illness.

Bigfoot Biomedical is dedicated to making lives healthier, safer, and easier by enabling optimized insulin delivery solutions accessible for all.

Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering our community to take control of diabetes.

DreaMed Diabetes is dedicated to enhancing the lives of insulin-dependent patients and their caregivers, empowering them with innovative personalized medicine and decision support technology.

Lilly unites caring with discovery to make life better for people around the world. We make medicines that help people live longer, healthier, more active lives.

Glooko brings your diabetes data together so you can better understand what’s impacting your glucose levels.

Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform.

JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D.

The Jaeb Center for Health Research was established in 1993 as a freestanding, nonprofit coordinating center for multi-center clinical trials and epidemiologic research. The Jaeb Center's focus is on projects involving eye disorders or type 1 diabetes.

Jupiter is a global team of strategy experts with a shared passion for shaping value, navigating market access and optimizing price for pharma and biotech innovators. Our team has extensive experience in consulting and industry, and as payers. We have contributed to or directed the pricing of 70% of the top 25 drugs on the market.

Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension.

Medtronic is a global leader in medical technology, services, and solutions. We collaborate with others to take on healthcare's greatest challenges.

Sanofi is a global biopharmaceutical company committed to healthcare solutions from prevention to treatment. We turn scientific discoveries into medicine to improve human health. Every day we dedicate our most important resource, our people, to support patients and families through their health journey.

At Tandem, we are not a diabetes division, we are a diabetes company. Our whole reason for being is to make the lives of people with diabetes better and better, through relentless innovation and revolutionary customer experience.

Tidepool is an open source, not-for-profit company focused on liberating data from diabetes devices, supporting researchers, and providing great, free software to people with diabetes and their care teams.

Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables.

Zealand Pharma is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other specialty disease areas with significant unmet medical needs.